Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06014281
Other study ID # 68784
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2023
Est. completion date December 31, 2024

Study information

Verified date April 2024
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will examine the effects of online meditation training on stress and anxiety in healthy participants. It will also examine the dose-response relationship between the amount of daily focused attention meditation practice and established mental health outcome measures.


Description:

This is a 16-week study with an 8-week meditation intervention, with a requirement of a minimum of 10 minutes of meditation practice each day. This study will recruit ~200 healthy subjects (18+ years) with no current or previous diagnosis of psychiatric or neurological disorders who are interested in learning about meditation but don't have long-term experience with meditation. Half of the participant pool will be randomly assigned to the meditation intervention, and the other half will get the wait-list control assignment. The control group will later receive its intervention, likely a few weeks after the completion of the active group's intervention. A focused-attention meditation technique (SOS meditation) will be used to train participants. Changes in participants' physiological markers (e.g., HRV, physical activity, respiration rate, sleep quality) will be evaluated using passive activity monitoring devices (e.g., Fitbit). Intervention-related changes in mental health will be assessed using web-based mental health and well-being surveys. Improvements in cognitive functioning will be assessed using web-based psychological tasks.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date December 31, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Able to follow basic instructions for prescreening and scheduling - Compliant with investigator instructions during the consent process and participation in the study - Is not already a regular meditation practitioner Exclusion Criteria: - Age <18 - People with a current diagnosis of psychiatric or neurological disorders - Be in current psychiatric treatment or medications - Hospitalized for psychiatric disorders in the past year or so. - Regular and long-term meditation practitioners - Non-English speaking - Non-USA mailing address to receive the activity tracker device - Vision or hearing impairment severe enough to interfere with study participation

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
SOS Meditation
Focused-attention meditation technique will be used to train participants, specifically the SOS meditation technique. The SOS meditation technique is an easy-to-learn approach where participants are instructed to dissociate their attention from physical awareness, thoughts, and emotions by mentally slowly repeating a calming word or phrase (chosen by the participant themselves). SOS Meditation Instructions: Close your eyes very gently, in a relaxed way, as you do when we go to sleep Your attention should be fully alert. Try not to put any strain on your eyes or try to look up. Focus your eyes about eight to ten inches into the field of darkness in front of you on the horizontal plane Mentally repeat the (chosen) calming word Sit lovingly and calmly to see what comes up, as if you were watching a movie screen and waiting to see what appears on it.

Locations

Country Name City State
United States Dept. of Psychiatry, Stanford University Stanford California

Sponsors (3)

Lead Sponsor Collaborator
Stanford University Feldman Foundation CA, Institute for Meditation and Inner Harmony

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Generalize Anxiety Disorder Questionnaire Score Anxiety as measured using Generalize Anxiety Disorder Questionnaire Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Primary Change in Pittsburgh Sleep Quality Index Questionnaire Score Sleep Quality measured using Pittsburgh sleep quality index (PSQI) Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Primary Change in Mind Wandering Questionnaire Score Mind wandering measured using the Mind Wandering Questionnaire Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Primary Resting Heart Rate Daily obtained from Activity Tracker wrist band Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
Primary Heart Rate Variability Daily obtained from Activity Tracker wrist band Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
Primary Change in Stroop Test Score Using the Stroop test, which measures the average reaction time between incongruent and congruent trials Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Primary Change in N-back Test Score Using the N-back test is a memory task where participants must remember letters from N trials ago. Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Secondary Change in Stress Scale Measure Questionnaire Score Stress measured using Perceived Stress Scale measure Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Secondary Change in Depression Questionnaire Score Depression measured using Patient Health Questionnaire Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Secondary Change in Quality of Life Scale Measures Questionnaire Score Quality of life measured using Quality of Life Scale measures Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Secondary Change Social Connectedness Scale-Revised Questionnaire Score Social Connectedness measured using Social Connectedness Scale-Revised Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Secondary Change in Rumination Reflection Questionnaire Score Rumination and reflection scales measured using Rumination Reflection Questionnaire Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Secondary Change in Brief Strengths Scale Questionnaire Score Strengths scale measured using Brief Strengths Scale measures individuals' Temperance Strength, Intellectual Strength, and Interpersonal Strength. Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Secondary Change in Sleep Quality Measure Daily obtained from Activity Tracker wrist band Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1